StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Regulators to take steps against short selling -CIM Magazine

<< Previous

Bullboard Posts

Next >>

Comment by StockscoutXon Apr 24, 2021 8:37pm

168 Views

Post# 33062474

RE:Regulators to take steps against short selling -CIM Magazine

It wasn't that bad when there was the tick test rule but regulators in 2012 abolished it. Goes to show how corrupted the system that controls the stock market has become. I am not surprised that StageZero and their shareholder could be victims of corrupt shorting practices. I am sure that StageZero would have a stock price much higher and not fallen as bad if were not for corrupt short selling. What happened to StageZero after the last CC wouldn't have stopped the fall of the SP but it wouldn't have been that bad of a drop. By the way, don't forget all stocks have been subject to corrupt short selling practices since the change in tick test rule.